Document Detail


Radiological assessment of necrosis in glioblastoma: variability and prognostic value.
MedLine Citation:
PMID:  9561517     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In a previous study, we found that the extent of necrosis was the only radiological feature which correlated significantly with survival in patients with glioblastoma. The aim of this paper was to evaluate the variability and prognostic value of the extent of the necrotic area as seen on contrast-enhanced MRI and CT in a larger series. We studied 72 patients who underwent surgical removal of supratentorial glioblastomas and had CT and/or MRI with contrast medium before surgery; 38, all undergoing the same treatment (surgery plus radiotherapy), were followed clinically. Necrosis within the tumour varied greatly, ranging from none (only 1 case) to involvement of 76% of the tumour. Survival data in the subgroup suggested that only patients with a small area of necrosis (less than 35% of the tumour) had a significantly longer survival time. When necrosis involved more than 35% of the mass, patients had a shorter survival time, without any further correlation with the extent of necrosis.
Authors:
A Pierallini; M Bonamini; P Pantano; F Palmeggiani; M Raguso; M F Osti; G Anaveri; L Bozzao
Related Documents :
2538387 - Oat cell carcinoma of the larynx. a study of six new cases.
12192567 - Phase 1 study to identify tumour hypoxia in patients with head and neck cancer using te...
15683667 - High precision conformal radiotherapy employing conservative margins in childhood benig...
20015387 - Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme.
21505457 - Performance status is the most powerful risk factor for early death among patients with...
3777087 - Treatment of trilateral retinoblastoma with vincristine and cyclophosphamide.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Neuroradiology     Volume:  40     ISSN:  0028-3940     ISO Abbreviation:  Neuroradiology     Publication Date:  1998 Mar 
Date Detail:
Created Date:  1998-06-19     Completed Date:  1998-06-19     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  1302751     Medline TA:  Neuroradiology     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  150-3     Citation Subset:  IM    
Affiliation:
Department of Neurological Sciences, University of Rome La Sapienza, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Brain / pathology*
Combined Modality Therapy
Contrast Media
Female
Gadolinium DTPA / diagnostic use
Glioblastoma / diagnosis*,  mortality,  therapy
Humans
Magnetic Resonance Imaging / methods*
Male
Middle Aged
Necrosis
Prognosis
Supratentorial Neoplasms / diagnosis*,  mortality,  therapy
Survival Analysis
Tomography, X-Ray Computed*
Chemical
Reg. No./Substance:
0/Contrast Media; 80529-93-7/Gadolinium DTPA

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hepatic cirrhosis: magnetisation transfer contrast in the globus pallidus.
Next Document:  Intracranial gas on CT after cardiopulmonary resuscitation: 4 cases.